Litcius/Paper detail

Malaria transmission-blocking vaccines Pfs230D1-EPA and Pfs25-EPA in Alhydrogel in healthy Malian adults; a phase 1, randomised, controlled trial

Issaka Sagara, Sara A. Healy, Mahamadoun H. Assadou, Mamady Koné, Bruce Swihart, Jennifer Kwan, Jonathan Fintzi, Kourane Sissoko, Bourama Kamaté, Yacouba Samake, Merepen A. Guindo, M’Bouye Doucoure, Karamoko Niaré, Amagana Dolo, Balla Diarra, Kelly M. Rausch, David L. Narum, David S Jones, Nicholas J. MacDonald, Daming Zhu, J. Patrick Gorres, Alemush Imeru, Rathy Mohan, Ismaila Théra, Irfan Zaidi, Fernando Salazar-Miralles, Junhui Duan, Jillian Neal, Robert Morrison, Olga Muratova, Daman Sylla, Elise M. O’Connell, Yimin Wu, Jen C. C. Hume, Mamadou B. Coulibaly, Charles Anderson, Sékou F. Traorè, Ogobara K. Doumbo, Patrick E. Duffy

2023The Lancet Infectious Diseases51 citationsDOIOpen Access PDF

Topics & Concepts

MalariaBlocking (statistics)Phase (matter)Transmission (telecommunications)MedicineVirologyImmunologyChemistryOrganic chemistryElectrical engineeringMathematicsStatisticsEngineeringMalaria Research and ControlMosquito-borne diseases and controlParasitic Diseases Research and Treatment
Malaria transmission-blocking vaccines Pfs230D1-EPA and Pfs25-EPA in Alhydrogel in healthy Malian adults; a phase 1, randomised, controlled trial | Litcius